查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2153699

生物可吸收骨移植替代物市場：全球市場預測，2026-2032年

Bioresorbable Bone-graft Substitute Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物可吸收骨移植替代物的市場規模將達到 37.9 億美元，年複合成長率為 15.08%。

主要市場統計數據
基準年 2025 14.1億美元
預計年份：2026年 15.9億美元
預測年份 2032 37.9億美元
複合年成長率 (%) 15.08%

生物可吸收骨移植替代品：概述

生物可吸收骨移植材料旨在透過逐漸分解並被再生組織取代來促進骨癒合。它們在重組外科、創傷治療、口腔顎顏面外科以及減輕植入永久性負擔的新方法中發揮著重要作用。臨床適用性取決於骨缺損的特徵、力學要求、操作特性、分解行為以及支持其安全性和癒合效果的證據。

融入臨床實務正在重塑競爭格局。

該領域正從關注新材料轉向關注臨床整合解決方案。研發人員和供應商優先考慮可預測的吸收性、結構性能、生物相容性、易於植入以及與微創技術的兼容性。外科醫生的熟悉程度、醫療規範、保險報銷條件、監管要求以及對比臨床證據的品質也會影響其應用。對分解和骨生成進行標準化評估對於贏得更廣泛的信任仍然至關重要。

人工智慧可以增強證據收集、設計和工作流程決策。

人工智慧（AI）可透過影像分析、缺陷特徵識別、輔助患者個體化治療方案製定以及改進術後評估等方式為該領域提供支援。機器學習工具還可以幫助研究人員評估材料成分、孔隙率、分解模式以及與生物組織的相互作用。其實際價值取決於具有代表性的資料集、透明的檢驗、臨床監督以及對醫療設備要求的遵守情況。人工智慧應作為外科醫生判斷和前瞻性臨床證據的補充，而非替代。

區域性見解：法規、基礎設施和臨床實踐因地區而異。

北美地區擁有先進的整形外科基礎設施、實證實踐以及積極運用數位化規劃。歐洲則將尖端的臨床研究與協調而嚴格的法規和品質要求結合。亞太地區擁有強大的製造和研發能力，但醫療保健的取得途徑和監管路徑卻各不相同。拉丁美洲受到醫院資源不平衡、依賴進口以及對成本效益解決方案的需求等問題的限制。中東地區受益於特定地區專科醫療的擴張，而非洲除了在採購、培訓和手術能力方面存在許多限制外，仍然面臨著巨大的未滿足臨床需求。

群體洞察：經濟和監管障礙會造成不同的部署環境。

東協市場醫療保健體系和監管成熟度各不相同，因此本地註冊和分銷能力至關重要。金磚國家擁有龐大的臨床需求，國內生產、報銷和採購條件也存在差異。歐盟受益於協調一致的政策框架，但需要嚴格的合格評定和上市後流程。七國集團（G7）國家通常擁有強大的科學研究生態系統和專業的醫療保健體系。海灣合作理事會（GCC）國家正在投資建設先進的醫療保健基礎設施和轉診機構，而北約成員國的醫療保健系統則極為多樣化，通常優先考慮醫療保健供應鏈的品質、應對力和韌性。

國家概況：國家優先事項決定臨床導入

澳洲和加拿大在地域分散的醫療服務方面既擁有專業技術，也面臨挑戰。巴西、墨西哥、印度、俄羅斯和南非必須在都市區提供先進治療的同時，兼顧更廣泛的醫療服務取得和採購的限制。中國、日本和韓國在醫療技術和研究能力方面表現卓越，但國家層級的監管和報銷政策會影響其應用。法國、德國、義大利、西班牙和英國優先考慮臨床證據、品質系統和醫療服務的價值，而美國則高度重視監管文件、醫生招聘、醫院經濟效益和基於結果的評估。

領導者行動指南：以綜合方式促進證據、可用性和可近性

產業領導者應優先考慮針對特定適應症的臨床證據，將治療結果（包括癒合、併發症、再次手術、手術和吸收）與公認的替代療法進行比較。產品開發應根據每項外科手術的機械和生物學要求定製材料特性，並輔以嚴格的生產控制和透明的分解數據。商業策略應著重於外科醫生培訓、影像和規劃工作流程、醫院價值分析以及保險報銷文件。區域實施應利用受監管的分銷管道、本地臨床夥伴關係和上市後監測，以識別不同患者群體和醫療機構之間的療效差異。

調查方法：基於證據的市場促進因素解讀

本執行摘要整合了生物材料、整形外科和重組手術實踐、醫療設備法規、醫療服務以及數位化臨床工具等領域的既有考慮，並以生物可吸收骨移植替代物的市場範圍為基礎。分析結果按指定區域、經濟和安全集團以及國家/地區進行分類。本分析著重於定性且檢驗的促進因素和限制因素，包括臨床效用、證據要求、基礎設施、取得途徑、法規以及工作流程整合。本摘要有意省略了市場估計和預測、市場規模計算、市場佔有率、預測以及公司特定評估。

結論：臨床療效和系統適用性是永續實施的決定性因素。

生物可吸收骨移植替代材料在以修復性、手術特異性和生物整合醫學為導向的更廣泛趨勢中發揮著至關重要的作用。其長期意義更取決於已證實的癒合效果、可靠的操作性、合適的機械性能、安全的分解以及與實際手術流程的兼容性，而不僅僅是可吸收性。將嚴謹的實證醫學證據與臨床醫生教育、監管合規、區域准入計劃和負責任的數位化創新相結合的領導企業，將更有利於支持永續的臨床應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物可吸收骨移植替代物的市場：以劑型分類

  • 堵塞
  • 顆粒
  • 粉末
  • 油灰
  • 海綿

第8章：生物可吸收骨移植替代材料市場：依外科應用分類

  • 牙科手術
  • 整形外科手術
  • 脊椎固定
  • 創傷修復

第9章：生物可吸收骨移植替代物市場：依最終用戶分類

  • 門診手術中心
  • 牙醫診所
  • 醫院
  • 研究機構
  • 專科診所

第10章：生物可吸收骨移植替代材料市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第11章：生物可吸收骨移植替代品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第12章：生物可吸收骨移植替代物市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第13章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第14章：公司簡介

  • Alphatec Holdings Inc.
  • Baxter International Inc.
  • Globus Medical Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • NuVasive Inc.
  • Orthofix Medical Inc.
  • RTI Surgical Holdings Inc.
  • SeaSpine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group NV
  • Xtant Medical Holdings Inc.
  • Zimmer Biomet Holdings Inc.

第15章 主要專家

Product Code: MRR-537DB9F46B8B

The Bioresorbable Bone-graft Substitute Market is projected to grow by USD 3.79 billion at a CAGR of 15.08% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.41 billion
Estimated Year [2026] USD 1.59 billion
Forecast Year [2032] USD 3.79 billion
CAGR (%) 15.08%

Bioresorbable Bone-Graft Substitutes: Executive Overview

Bioresorbable bone-graft substitutes are designed to support bone healing while gradually breaking down and being replaced by regenerated tissue. Their relevance is linked to reconstructive surgery, trauma care, dental and maxillofacial procedures, and evolving approaches to reducing permanent implant burden. Clinical suitability depends on defect characteristics, mechanical requirements, handling properties, degradation behavior, and evidence supporting safety and healing outcomes.

Clinical Integration Is Shaping the Competitive Landscape

The field is shifting from material novelty toward clinically integrated solutions. Developers and providers are emphasizing predictable resorption, structural performance, biocompatibility, ease of placement, and compatibility with minimally invasive techniques. Adoption is also influenced by surgeon familiarity, institutional protocols, reimbursement conditions, regulatory requirements, and the quality of comparative clinical evidence. Standardized evaluation of degradation and bone formation remains important for broader confidence.

Artificial Intelligence Strengthens Evidence, Design, and Workflow Decisions

Artificial intelligence can support this field by analyzing imaging, identifying defect characteristics, assisting patient-specific planning, and improving postoperative assessment. Machine-learning tools may also help researchers evaluate material composition, porosity, degradation patterns, and interactions with biological tissues. Practical value depends on representative datasets, transparent validation, clinical oversight, and compliance with medical-device requirements. AI should augment-not replace-surgeon judgment and prospective clinical evidence.

Regional Insights: Regulation, Infrastructure, and Clinical Practice Vary

North America is characterized by advanced orthopedic infrastructure, evidence-focused adoption, and active use of digital planning. Europe combines sophisticated clinical research with harmonized, yet demanding, regulatory and quality expectations. Asia-Pacific includes strong manufacturing and research capabilities alongside varied healthcare access and regulatory pathways. Latin America is influenced by uneven hospital resources, import dependence, and the need for cost-conscious solutions. The Middle East is supported by expanding specialist care in selected hubs, while Africa presents substantial unmet clinical need alongside constraints in procurement, training, and surgical capacity.

Group Insights: Economic and Regulatory Blocs Create Distinct Adoption Contexts

ASEAN markets reflect diverse healthcare systems and regulatory maturity, making local registration and distribution capabilities important. BRICS economies combine significant clinical need with varied domestic manufacturing, reimbursement, and procurement conditions. The European Union benefits from coordinated policy structures but requires rigorous conformity and post-market processes. G7 countries generally possess strong research ecosystems and specialist care capacity. GCC states are investing in advanced healthcare infrastructure and referral centers, while NATO members span highly diverse health systems but often emphasize quality, readiness, and resilient medical supply chains.

Country Insights: National Priorities Determine Clinical Uptake

Australia and Canada combine specialist expertise with geographically distributed care challenges. Brazil, Mexico, India, Russia, and South Africa must balance advanced urban treatment with broader access and procurement constraints. China, Japan, and South Korea have substantial medical-technology and research capabilities, with national regulatory and reimbursement considerations shaping adoption. France, Germany, Italy, Spain, and the United Kingdom emphasize clinical evidence, quality systems, and health-service value, while the United States places strong weight on regulatory documentation, physician adoption, hospital economics, and outcomes-based evaluation.

Actions for Leaders: Build Evidence, Usability, and Access Together

Industry leaders should prioritize indication-specific clinical evidence that compares healing, complications, reoperation, handling, and resorption outcomes against accepted alternatives. Product development should align material properties with the mechanical and biological demands of each procedure, supported by robust manufacturing controls and transparent degradation data. Commercial strategies should address surgeon training, imaging and planning workflows, hospital value analysis, and reimbursement documentation. Regional execution should use compliant distribution, local clinical partnerships, and post-market surveillance capable of identifying performance differences across patient populations and care settings.

Research Methodology: Evidence-Led Interpretation of Market Drivers

This executive summary uses the defined market scope of bioresorbable bone-graft substitutes and synthesizes established considerations in biomaterials, orthopedic and reconstructive practice, medical-device regulation, healthcare delivery, and digital clinical tools. Insights are organized across the specified regions, economic and security groups, and countries. The analysis emphasizes qualitative, verifiable drivers and constraints, including clinical utility, evidence requirements, infrastructure, access, regulation, and workflow integration. It intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments.

Conclusion: Clinical Proof and System Fit Will Define Sustainable Adoption

Bioresorbable bone-graft substitutes have a role in the broader movement toward restorative, procedure-specific, and biologically integrated care. Their long-term relevance will depend less on resorption alone than on demonstrated healing outcomes, dependable handling, appropriate mechanical performance, safe degradation, and fit with real-world surgical workflows. Leaders that combine rigorous evidence with clinician education, regulatory discipline, regional access planning, and responsible digital innovation will be better positioned to support durable clinical adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bioresorbable Bone-graft Substitute Market, by Delivery Form

  • 7.1. Introduction
  • 7.2. Blocks
  • 7.3. Granules
  • 7.4. Powder
  • 7.5. Putty
  • 7.6. Sponges

8. Bioresorbable Bone-graft Substitute Market, by Surgical Application

  • 8.1. Introduction
  • 8.2. Dental Surgery
  • 8.3. Orthopedic Surgery
  • 8.4. Spinal Fusion
  • 8.5. Trauma Repair

9. Bioresorbable Bone-graft Substitute Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Dental Clinics
  • 9.4. Hospitals
  • 9.5. Research Institutes
  • 9.6. Specialty Clinics

10. Bioresorbable Bone-graft Substitute Market, by Region

  • 10.1. Introduction
  • 10.2. Asia-Pacific
  • 10.3. North America
  • 10.4. Latin America
  • 10.5. Europe
  • 10.6. Middle East
  • 10.7. Africa

11. Bioresorbable Bone-graft Substitute Market, by Group

  • 11.1. Introduction
  • 11.2. ASEAN
  • 11.3. GCC
  • 11.4. European Union
  • 11.5. BRICS
  • 11.6. G7
  • 11.7. NATO

12. Bioresorbable Bone-graft Substitute Market, by Country

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. United Kingdom
  • 12.7. Germany
  • 12.8. France
  • 12.9. Russia
  • 12.10. Italy
  • 12.11. Spain
  • 12.12. China
  • 12.13. India
  • 12.14. Japan
  • 12.15. Australia
  • 12.16. South Korea

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Concentration Analysis, 2025
    • 13.2.1. Concentration Ratio (CR)
    • 13.2.2. Herfindahl Hirschman Index (HHI)
  • 13.3. Recent Developments & Impact Analysis, 2025
  • 13.4. Product Portfolio Analysis, 2025
  • 13.5. Benchmarking Analysis, 2025

14. Company Profiles

  • 14.1. Alphatec Holdings Inc.
  • 14.2. Baxter International Inc.
  • 14.3. Globus Medical Inc.
  • 14.4. Integra LifeSciences Holdings Corporation
  • 14.5. Johnson & Johnson
  • 14.6. Medtronic plc
  • 14.7. NuVasive Inc.
  • 14.8. Orthofix Medical Inc.
  • 14.9. RTI Surgical Holdings Inc.
  • 14.10. SeaSpine Holdings Corporation
  • 14.11. Smith & Nephew plc
  • 14.12. Stryker Corporation
  • 14.13. Wright Medical Group N.V.
  • 14.14. Xtant Medical Holdings Inc.
  • 14.15. Zimmer Biomet Holdings Inc.

15. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Bioresorbable Bone-graft Substitute Market, Years Considered for the Study
  • FIGURE 2. Global Bioresorbable Bone-graft Substitute Market, Research Design
  • FIGURE 3. Global Bioresorbable Bone-graft Substitute Market, Research Framework
  • FIGURE 4. Global Bioresorbable Bone-graft Substitute Market, Data Triangulation
  • FIGURE 5. Global Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2025 vs 2032 (%)
  • FIGURE 7. Global Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2025 vs 2032 (%)
  • FIGURE 9. Global Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Bioresorbable Bone-graft Substitute Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 11. Global Bioresorbable Bone-graft Substitute Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Bioresorbable Bone-graft Substitute Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 13. Global Bioresorbable Bone-graft Substitute Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Bioresorbable Bone-graft Substitute Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 15. Global Bioresorbable Bone-graft Substitute Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 16. Global Bioresorbable Bone-graft Substitute Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Bioresorbable Bone-graft Substitute Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Bioresorbable Bone-graft Substitute Market Segmentation & Coverage
  • TABLE 2. Global Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 4. Global Blocks Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Blocks Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Blocks Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Granules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Granules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Granules Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Powder Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Powder Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Powder Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Putty Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Putty Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Putty Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Sponges Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Sponges Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Sponges Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 20. Global Dental Surgery Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Dental Surgery Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Dental Surgery Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Orthopedic Surgery Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Orthopedic Surgery Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Orthopedic Surgery Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Spinal Fusion Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Spinal Fusion Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Spinal Fusion Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Trauma Repair Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 30. Global Trauma Repair Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 31. Global Trauma Repair Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 32. Global Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 33. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Dental Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Dental Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Dental Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 51. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 52. Asia-Pacific Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 53. North America Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. North America Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 55. North America Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 56. North America Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 57. Latin America Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Latin America Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 59. Latin America Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 60. Latin America Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 61. Europe Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Europe Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 63. Europe Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 64. Europe Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 65. Middle East Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Middle East Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 67. Middle East Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 68. Middle East Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 69. Africa Bioresorbable Bone-graft Substitute Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Africa Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 71. Africa Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 72. Africa Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 73. Global Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. ASEAN Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. ASEAN Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 76. ASEAN Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 77. ASEAN Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 78. GCC Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 79. GCC Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 80. GCC Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 81. GCC Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 82. European Union Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. European Union Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 84. European Union Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 85. European Union Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 86. BRICS Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 87. BRICS Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 88. BRICS Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 89. BRICS Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 90. G7 Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 91. G7 Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 92. G7 Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 93. G7 Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 94. NATO Bioresorbable Bone-graft Substitute Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. NATO Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 96. NATO Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 97. NATO Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 98. Global Bioresorbable Bone-graft Substitute Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 99. United States Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 100. United States Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 101. United States Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 102. United States Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 103. Canada Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 104. Canada Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 105. Canada Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 106. Canada Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 107. Mexico Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 108. Mexico Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 109. Mexico Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 110. Mexico Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 111. Brazil Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 112. Brazil Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 113. Brazil Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 114. Brazil Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 115. United Kingdom Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 116. United Kingdom Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 117. United Kingdom Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 118. United Kingdom Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 119. Germany Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 120. Germany Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 121. Germany Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 122. Germany Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 123. France Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 124. France Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 125. France Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 126. France Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 127. Russia Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 128. Russia Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 129. Russia Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 130. Russia Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 131. Italy Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 132. Italy Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 133. Italy Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 134. Italy Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 135. Spain Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 136. Spain Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 137. Spain Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 138. Spain Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 139. China Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 140. China Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 141. China Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 142. China Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 143. India Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 144. India Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 145. India Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 146. India Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 147. Japan Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 148. Japan Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 149. Japan Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 150. Japan Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 151. Australia Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 152. Australia Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 153. Australia Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 154. Australia Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 155. South Korea Bioresorbable Bone-graft Substitute Market Size, 2017-2032 (USD Million)
  • TABLE 156. South Korea Bioresorbable Bone-graft Substitute Market Size, by Delivery Form, 2017-2032 (USD Million)
  • TABLE 157. South Korea Bioresorbable Bone-graft Substitute Market Size, by Surgical Application, 2017-2032 (USD Million)
  • TABLE 158. South Korea Bioresorbable Bone-graft Substitute Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 159. Global Bioresorbable Bone-graft Substitute Market Share, by Key Player, 2025
  • TABLE 160. Global Bioresorbable Bone-graft Substitute Market, Key Experts